However, these treatments are not effective
Studies suggest this dual approach produces a 3-5 fold increase in growth hormone release compared to either peptide alone, while maintaining natural pulsatile secretion patterns
CJC-1295 naming is messy: FDA evaluated multiple CJC-1295-related bulk substances because no-DAC, DAC, free-base, acetate, and TFA naming can be inconsistent
In the ATTAIN-1 Phase 3 trial, participants with obesity lost an average of 11.2% of their body weight over 72 weeks on the highest dose
S.KoutsampasopoulosK.et al (2019)
Notable In 2024 a Reddit user shared images of their Mochi Health shipment, which had been cooled with popsicles